Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics

被引：0
|
作者：
Yun, Jiwon [1 ]
Kim, Jung-Ah [2 ]
Hwang, Byungjin [3 ]
Park, Hee Sue [4 ]
Im, Kyongok [5 ,6 ]
Kim, Sung-Min [7 ]
Jeong, Dajeong [1 ]
Lim, Kyu Min [7 ]
Bang, Duhee [3 ]
Lee, Dong Soon [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[2] Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea
[3] Yonsei Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea
[4] Chungbuk Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[5] Inst Reprod Med, Seoul, South Korea
[6] Populat Med Res Ctr, Seoul, South Korea
[7] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
来源：
BLOOD | 2018年 / 132卷
关键词：
Myeloproliferative neoplasms; next-generation sequencing; triple negative MPN; chromosome; FISH; telomere;
D O I：
10.1182/blood-2018-99-118013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations
    Millecker, Laura
    Lennon, Patrick A.
    Verstovsek, Srdan
    Barkoh, Bedia
    Galbincea, John
    Hu, Peter
    Chen, Su S.
    Jones, Dan
    CANCER GENETICS AND CYTOGENETICS, 2010, 197 (01) : 1 - 7
  • [42] Clinicopathologic Features of Myeloid Neoplasms Harboring Double Mutated JAK2, MPL or CALR
    He, Rong
    Ollila, Paul
    Zhang, Xi
    Yuan, Ji
    Shi, Min
    Rangan, Aruna
    Chen, Dong
    Viswanatha, David
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S19 - S19
  • [43] Correlation analysis between JAK2, MPL, and CALR mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics
    Lang, Tao
    Nie, Yuling
    Wang, Zengsheng
    Huang, Qin
    An, Li
    Wang, Yichun
    Wufuer, Guzailinuer
    Maimaiti, Aziguli
    Fu, Ling
    Li, Yan
    Zhang, Xiaoyan
    Aisimutula, Aihemaitijiang
    Wang, Xiaomin
    Zhu, Lin
    Liu, Hong
    Mao, Min
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (11) : 4650 - 4659
  • [44] The Clinical Characteristics and Outcomes of JAK2/ CALR/MPL Mutation Related Myeloproliferative Neoplasms- A Single Centre Study from Malaysia
    Baizura, Z. Nur
    Cheong, C. S.
    Anuar, A.
    Nadarajan, V. S.
    Bee, P. C.
    Chin, E. F. M.
    Khairullah, S.
    Liong, C. C.
    Zamri, Y.
    Gan, G. G.
    IIUM MEDICAL JOURNAL MALAYSIA, 2025, 24 (01): : 49 - 56
  • [45] Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing
    Thompson, Ella R.
    Nguyen, Tamia
    Kankanige, Yamuna
    Yeh, Paul
    Ingbritsen, Michael
    McBean, Michelle
    Semple, Timothy
    Arnau, Gisela Mir
    Burbury, Kate
    Lee, Nora
    Khot, Amit
    Westerman, David
    Blombery, Piers
    HAEMATOLOGICA, 2021, 106 (01) : 313 - 315
  • [46] Targeting JAK2 in the therapy of myeloproliferative neoplasms
    Reddy, Mamatha M.
    Deshpande, Anagha
    Sattler, Martin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (03) : 313 - 324
  • [47] JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Tefferi, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 20 - 21
  • [48] New JAK2 inhibitors for myeloproliferative neoplasms
    Quintas-Cardama, Alfonso
    Verstovsek, Srdan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (07) : 961 - 972
  • [49] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
    Vannucchi, Alessandro M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (01) : 22 - 28
  • [50] JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
    Bader, Michael Stephan
    Meyer, Sara Christina
    PHARMACEUTICALS, 2022, 15 (02)
12345